Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations

Abstract

Arylsulfatase A (ASA) knockout mice represent an animal model for the lysosomal storage disease metachromatic leukodystrophy (MLD). Stem cell gene therapy with bone marrow overexpressing the human ASA cDNA from a retroviral vector resulted in the expression of high enzyme levels in various tissues. Treatment partially reduces sulfatide storage in livers exceeding 18 ng ASA/mg tissue, while complete reduction was observed in livers exceeding 50 ng ASA/mg tissue. This corresponds to about 80% and 200% of normal enzyme activity. Similar values seem to apply for kidney. A partial correction of the lipid metabolism was detectable in the brain where the galactoerebroside/sulfatide ratio, which is diminished in ASA-deficient mice, increased upon treatment. This partial correction was accompanied by amelioration of neuropathology; axonal cross-sectional areas, which are reduced in deficient mice, were significantly increased in the saphenic and sciatic nerve but not in the optic nerve. Behavioral tests suggest some improvement of neuromotor abilities. The gene transfer did not delay the degeneration occurring in the acoustic ganglion of ASA-deficient animals. The limited success of the therapy appears to be due to the requirement of unexpected high levels of ASA for correction of the metabolic defect.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Kolodny E.H., Fluharty A.L. . Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis Scriver CR, Beaudet AL, Sly WS, Valle D (eds); The Metabolic and Molecular Bases of Inherited Disease McGraw-Hill 1995 pp 2693–2740

  2. Hess B. et al. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy Proc Natl Acad Sci USA 1996 93: 14821 14821

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gieselmann V. et al. Metachromatic leukodystrophy: molecular genetics and an animal model J Inher Metab Dis 1998 21: 564 564

    Article  CAS  PubMed  Google Scholar 

  4. D'Hooge R. et al. Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice Neurosci Lett 1999 273: 93 93

    Article  CAS  PubMed  Google Scholar 

  5. D'Hooge R. et al. Decline in brain stem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice Brain Res 1999 847: 352 352

    Article  CAS  PubMed  Google Scholar 

  6. Neufeld E.F. . Lysosomal storage diseases Annu Rev Biochem 1991 60: 257 257

    Article  CAS  PubMed  Google Scholar 

  7. Schluff P. et al. Localization of receptors for endocytosis of lysosomal enzymes on different brain cells J Inher Metab Dis 1998 21: 313 313

    Article  CAS  PubMed  Google Scholar 

  8. Stewart K. et al. Uptake of α-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro Gene Therapy 1997 4: 63 63

    Article  CAS  PubMed  Google Scholar 

  9. Krall W.J. et al. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation Blood 1994 83: 2737 2737

    CAS  PubMed  Google Scholar 

  10. Kennedy D.W., Abkowitz J.L. . Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model Blood 1997 90: 986 986

    CAS  PubMed  Google Scholar 

  11. Hoogerbrugge P.M. et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European group for bone marrow transplantation Lancet 1995 345: 1398 1398

    Article  CAS  PubMed  Google Scholar 

  12. van Figura K., Gieselmann V., Jacken J. . Metachromatic leukodystrophy: sulfatide lipidosis Scriver CR (eds); The Metabolic and Molecular Bases of Inherited Disease McGraw-Hill 2000 pp 3695–3724

  13. Krivit W. et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation N Engl J Med 1990 322: 28 28

    Article  CAS  PubMed  Google Scholar 

  14. Matzner U. et al. Long-term expression and transfer of arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A cDNA from a retroviral vector Gene Therapy 2000 7: 1250 1250

    Article  CAS  PubMed  Google Scholar 

  15. Penzien J.M. et al. Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease Am J Hum Genet 1993 52: 557 557

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Leinekugel P., Michel S., Conzelmann E., Sandhoff K. . Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease Hum Genet 1992 88: 513 513

    Article  CAS  PubMed  Google Scholar 

  17. Matzner U., Habetha M., Gieselmann V. . Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells Gene Therapy 2000 7: 805 805

    Article  CAS  PubMed  Google Scholar 

  18. Lutzko C. et al. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine α-L-iduronidase deficiency Blood 1999 93: 1895 1895

    CAS  PubMed  Google Scholar 

  19. Barton N.W. et al. Replacement therapy for inherited enzyme deficiency – macrophage-targeted glucocerebrosidase for Gaucher's disease N Engl J Med 1991 324: 1464 1464

    Article  CAS  PubMed  Google Scholar 

  20. Norflus F. et al. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestation in Sandhoff disease mice J Clin Invest 1998 101: 1881 1881

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Norton W.T., Poduslo S.E. . Biochemical studies of metachromatic leukodystrophy in three siblings Acta Neuropathol (Berl) 1982 57: 188 188

    Article  CAS  Google Scholar 

  22. Rosengren B., Fredman P., Mansson J.E., Svennerholm L. . Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain J Neurochem 1989 52: 1035 1035

    Article  CAS  PubMed  Google Scholar 

  23. Ginsberg L., Gershfeld N.L. . Membrane bilayer instability and the pathogenesis of disorders of myelin Neurosci Lett 1991 130: 133 133

    Article  CAS  PubMed  Google Scholar 

  24. Scott J.E., Dorling J. . Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions Histochemie 1965 5: 221 221

    Article  CAS  PubMed  Google Scholar 

  25. Baum H., Dodgson K.S., Spencer B. . The assay of aryl sulfatase A and B in human urine Clin Chim Acta 1959 4: 453 453

    Article  CAS  PubMed  Google Scholar 

  26. Sommerlade H.J. et al. Glycosylation and phosphorylation of arylsulfatase A J Biol Chem 1994 269: 20977 20977

    CAS  PubMed  Google Scholar 

  27. Svennerholm L., Fredman P. . A procedure for the quantitative isolation of brain gangliosides Biochim Biophys Acta 1980 617: 97 97

    Article  CAS  PubMed  Google Scholar 

  28. Svennerholm L. et al. Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis J Neurochem 1987 49: 1772 1772

    Article  CAS  PubMed  Google Scholar 

  29. Jones B.J., Roberts D.J. . The quantiative measurement of motor incoordination in naive mice using an accelerating rotarod J Pharm Pharmacol 1968 20: 302 302

    Article  CAS  PubMed  Google Scholar 

  30. Schierau A. et al. Interaction of arylsulfatase A with UDP-N-acetylglucosamine:lysosomal enzyme-N-acetylglucosamine-1-phosphotransferase J Biol Chem 1999 274: 3651 3651

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank H Simonis for excellent technical assistance. This work was supported by the Fund of Scientific Research of Flanders (No. G.0027.97) and the Bundesministerium für Bildung und Forschung (BMBF). R D'Hooge is a postdoctoral fellow of the Fonds voor Wetenschappelijk Onderzoek (FWO).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matzner, U., Hartmann, D., Lüllmann-Rauch, R. et al. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. Gene Ther 9, 53–63 (2002). https://doi.org/10.1038/sj.gt.3301593

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301593

Keywords

This article is cited by

Search

Quick links